pISSN 1976-2283
eISSN 2005-1212

Cited by CrossRef (14)

  1. Bastian Neesgaard, Morten Ruhwald, Nina Weis. Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review. WJH 2017;9:677
    https://doi.org/10.4254/wjh.v9.i14.677
  2. Hu Li, Meng-Hao Huang, Jian-Dong Jiang, Zong-Gen Peng. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. WJG 2018;24:5297
    https://doi.org/10.3748/wjg.v24.i47.5297
  3. Claudia Mascia, Serena Vita, Paola Zuccalà, Raffaella Marocco, Tiziana Tieghi, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Irene Pozzetto, Caterina Furlan, Fabio Mengoni, Claudio Maria Mastroianni, Vincenzo Vullo, Miriam Lichtner, Ravi Jhaveri. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. PLoS ONE 2017;12:e0179400
    https://doi.org/10.1371/journal.pone.0179400
  4. Renwen Zhang, Cuiping Shao, Na Huo, Minran Li, Xiaoyuan Xu. Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China. Gut Liver 2016;10
    https://doi.org/10.5009/gnl15162
  5. Claudia Mascia, Miriam Lichtner, Paola Zuccalà, Serena Vita, Tiziana Tieghi, Raffaella Marocco, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Michela Campagna, Francesco Schiavone, Fabio Mengoni, Gianluca Russo, Claudio Maria Mastroianni, Vincenzo Vullo. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clinics and Research in Hepatology and Gastroenterology 2017;41:644
    https://doi.org/10.1016/j.clinre.2017.04.007
  6. Michela E Burlone, Rosalba Minisini, Mario Pirisi. Interferon-stimulated gene pathways in the treatment of viral hepatitis. Future Virology 2012;7:361
    https://doi.org/10.2217/fvl.12.21
  7. Linda Petrone, Teresa Chiacchio, Valentina Vanini, Elisa Petruccioli, Gilda Cuzzi, Cristina Di Giacomo, Luigia Pucci, Marzia Montalbano, Raffaella Lionetti, Angela Testa, Daniele Lapa, Assunta Navarra, Ubaldo Visco-Comandini, Delia Goletti. High urine IP-10 levels associate with chronic HCV infection. Journal of Infection 2014;68:591
    https://doi.org/10.1016/j.jinf.2014.02.008
  8. Yoshihiko Aoki, Masaya Sugiyama, Kazumoto Murata, Sachiyo Yoshio, Masayuki Kurosaki, Satoru Hashimoto, Hiroshi Yatsuhashi, Hideyuki Nomura, Jong-Hon Kang, Tsutomu Takeda, Shigeko Naito, Tatsuji Kimura, Yoko Yamagiwa, Masaaki Korenaga, Masatoshi Imamura, Naohiko Masaki, Namiki Izumi, Masayoshi Kage, Masashi Mizokami, Tatsuya Kanto. Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. J Gastroenterol 2015;50:894
    https://doi.org/10.1007/s00535-014-1023-2
  9. Bastian Neesgaard, Morten Ruhwald, Henrik B. Krarup, Nina Weis, Ratna B. Ray. Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail. PLoS ONE 2018;13:e0201629
    https://doi.org/10.1371/journal.pone.0201629
  10. P. Farci, K. Wollenberg, G. Diaz, R. E. Engle, M. E. Lai, P. Klenerman, R. H. Purcell, O. G. Pybus, H. J. Alter. Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proceedings of the National Academy of Sciences 2012;109:14562
    https://doi.org/10.1073/pnas.1210592109
  11. Tung-Hsia Liu, Ren-Hua Chung, Sheng-Chang Wang, Chiu-Ping Fang, Hsiao-Hui Tsou, Chia-Lung Shih, Hsiang-Wei Kuo, Yun Wang, Yu-Li Liu, Wen-Lung Ma. Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine. PLoS ONE 2017;12:e0187639
    https://doi.org/10.1371/journal.pone.0187639
  12. Roba M. Talaat, Tarek A. Salem, Samir El-Masry, Arafat Imbarek, Mohamed Mokhles, Amal Abdel-Aziz. Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma. J. Med. Virol. 2014;86:1120
    https://doi.org/10.1002/jmv.23932
  13. Dilek Yıldız Sevgi, Banu Bayraktar, Alper Gündüz, Banu Yılmaz Özgüven, Alper Togay, Emin Bulut, Nuray Uzun, İlyas Dökmetaş. Serum soluble urokinase-type plasminogen activator receptor and interferon-γ-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B. Wien Klin Wochenschr 2016;128:28
    https://doi.org/10.1007/s00508-015-0886-4
  14. Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjaroen, Pisit Tangkijvanich, Sombat Treeprasertsuk, Panarat Thaimai, Rujipat Wasitthankasem, Yong Poovorawan, Piyawat Komolmit, Chen-Hua Liu. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. PLoS ONE 2015;10:e0137365
    https://doi.org/10.1371/journal.pone.0137365